(Q28296557)

Laia Bruni

6

0 references

Susanne Krüger Kjaer

Susanne Kruger Kjaer

8

0 references

Guillermo Tortolero-Luna

7

Guillermo Tortolero-Luna

0 references

Mark Schiffman

3

Mark Schiffman

0 references

Ann N Burchell

2

Ann N Burchell

0 references

Nubia Muñoz

9

Francesc Xavier Bosch José

Nubia Muñoz

0 references

1

F Xavier Bosch

0 references

author name string

Anna R Giuliano

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

4

0 references

language of work or name

English

0 references

publication date

19 August 2008

0 references

published in

Vaccine

0 references

volume

26 Suppl 10

0 references

page(s)

K1-16

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Sexual behaviour in context: a global perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Global control of sexually transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Prevention strategies for sexually transmitted infections: importance of sexual network structure and epidemic phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Sexual networks: implications for the transmission of sexually transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

The web of human sexual contacts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Large-network concepts and small-network characteristics: fixed and variable factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Chains of Affection: The Structure of Adolescent Romantic and Sexual Networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Modern day influences on sexual behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Higher prevalence of human papillomavirus infection in migrant women from Latin America in Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Migration and HIV: an epidemiological study of Montrealers of Haitian origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Sexual risk behavior of married men and women in Bangladesh associated with husbands' work migration and living apart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Migration, behaviour change and HIV/STD risks in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Risk factors of sexually transmitted infections among migrant and non-migrant sexual partnerships from rural South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Risk assessment to guide the prevention of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

ASC, TBS, and the power of ALTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Human papillomavirus infections with multiple types and risk of cervical neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

inferred from DOI database lookup

7 January 2021

based on heuristic

A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.064

10.1016/J.VACCINE.2008.05.064

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18847553

1 reference

Consolidated OpenCitations Corpus – April 2017